Listing 1 - 3 of 3 |
Sort by
|
Choose an application
The 1992 creation of the National HIV/AIDS Program was a fundamental step for Argentina to reach the second lowest burden of HIV/AIDS in South America. From 2000 to 2010, Argentina further reduced the already low HIV/AIDS incidence of 15.9 per 100,000 by 25 percent and reduced the burden by 21 percent. This study analyzes the national and inter-provincial burden of disease, the demographics of new HIV cases, the demand and supply-sides of service delivery, and conducts a cost-benefit analysis of the National HIV/AIDS Program over the last decade. Though the National HIV/AIDS Program was an ins
AIDS (Disease) -- Argentina -- Epidemiology. --- HIV infections -- Argentina. --- Medicine. --- AIDS (Disease) --- HIV infections --- Sexually Transmitted Diseases, Viral --- Immunologic Deficiency Syndromes --- Lentivirus Infections --- Slow Virus Diseases --- Retroviridae Infections --- Sexually Transmitted Diseases --- Immune System Diseases --- Virus Diseases --- Diseases --- RNA Virus Infections --- Acquired Immunodeficiency Syndrome --- HIV Infections --- Public Health --- Health & Biological Sciences --- Communicable Diseases --- Epidemiology --- Argentina --- HTLV-III Infections --- HTLV-III-LAV Infections --- T-Lymphotropic Virus Type III Infections, Human --- HIV Infection --- HTLV III Infections --- HTLV III LAV Infections --- HTLV-III Infection --- HTLV-III-LAV Infection --- Infection, HIV --- Infection, HTLV-III --- Infection, HTLV-III-LAV --- Infections, HIV --- Infections, HTLV-III --- Infections, HTLV-III-LAV --- T Lymphotropic Virus Type III Infections, Human --- Acquired Immune Deficiency Syndrome --- Acquired Immuno-Deficiency Syndrome --- AIDS --- Immunodeficiency Syndrome, Acquired --- Immunologic Deficiency Syndrome, Acquired --- Acquired Immuno Deficiency Syndrome --- Acquired Immuno-Deficiency Syndromes --- Acquired Immunodeficiency Syndromes --- Immuno-Deficiency Syndrome, Acquired --- Immuno-Deficiency Syndromes, Acquired --- Immunodeficiency Syndromes, Acquired --- Syndrome, Acquired Immuno-Deficiency --- Syndrome, Acquired Immunodeficiency --- Syndromes, Acquired Immuno-Deficiency --- Syndromes, Acquired Immunodeficiency --- Infections, RNA Virus --- Infection, RNA Virus --- RNA Virus Infection --- Virus Infection, RNA --- Virus Infections, RNA --- Viral Diseases --- Viral Infections --- Virus Infections --- Disease, Viral --- Disease, Virus --- Diseases, Viral --- Diseases, Virus --- Infection, Viral --- Infection, Virus --- Infections, Viral --- Infections, Virus --- Viral Disease --- Viral Infection --- Virus Disease --- Virus Infection --- Diseases of Immune System --- Immune Diseases --- Immunological Diseases --- Immune Disorders --- Immunologic Diseases --- Disease, Immune --- Disease, Immune System --- Disease, Immunologic --- Disease, Immunological --- Diseases, Immune --- Diseases, Immune System --- Diseases, Immunologic --- Diseases, Immunological --- Disorder, Immune --- Disorders, Immune --- Immune Disease --- Immune Disorder --- Immune System Disease --- Immunologic Disease --- Immunological Disease --- STDs --- STIs --- Sexually Transmitted Infections --- Venereal Diseases --- Disease, Sexually Transmitted --- Disease, Venereal --- Diseases, Sexually Transmitted --- Diseases, Venereal --- Infection, Sexually Transmitted --- Infections, Sexually Transmitted --- STI --- Sexually Transmitted Disease --- Sexually Transmitted Infection --- Transmitted Infection, Sexually --- Transmitted Infections, Sexually --- Venereal Disease --- Infections, Retroviridae --- Infections, Retrovirus --- Retrovirus Infections --- Infection, Retroviridae --- Infection, Retrovirus --- Retroviridae Infection --- Retrovirus Infection --- Disease, Slow Virus --- Diseases, Slow Virus --- Slow Virus Disease --- Virus Disease, Slow --- Virus Diseases, Slow --- Infections, Lentivirus --- Infection, Lentivirus --- Lentivirus Infection --- Deficiency Syndrome, Immunologic --- Deficiency Syndromes, Antibody --- Deficiency Syndromes, Immunologic --- Immunologic Deficiency Syndrome --- Immunological Deficiency Syndromes --- Antibody Deficiency Syndrome --- Antibody Deficiency Syndromes --- Deficiency Syndrome, Antibody --- Deficiency Syndrome, Immunological --- Deficiency Syndromes, Immunological --- Immunological Deficiency Syndrome --- Syndrome, Antibody Deficiency --- Syndrome, Immunologic Deficiency --- Syndrome, Immunological Deficiency --- Syndromes, Antibody Deficiency --- Syndromes, Immunologic Deficiency --- Syndromes, Immunological Deficiency --- Antibodies --- Sexually Transmitted Disease, Viral --- Viral Sexually Transmitted Disease --- Viral Sexually Transmitted Diseases --- Viral Venereal Diseases --- Venereal Diseases, Viral --- Disease, Viral Venereal --- Diseases, Viral Venereal --- Venereal Disease, Viral --- Viral Venereal Disease --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Acquired immune deficiency syndrome --- Acquired immunodeficiency syndrome --- Acquired immunological deficiency syndrome --- deficiency --- HIV Coinfection --- Coinfection, HIV --- Coinfections, HIV --- HIV Coinfections --- CD4-Positive T-Lymphocytes --- HIV-1 --- AIDS Arteritis, Central Nervous System --- Venereology --- Reproductive Tract Infections --- XMRV Infection --- Xenotropic MuLV-related Virus Infection --- Xenotropic Murine Leukemia Virus-related Virus Infection --- Infection, XMRV --- Infections, XMRV --- XMRV Infections --- Xenotropic MuLV related Virus Infection --- Xenotropic Murine Leukemia Virus related Virus Infection --- Lentivirus infections --- Sexually transmitted diseases --- Immunological deficiency syndromes --- Virus-induced immunosuppression --- Immune System Disorders --- Disorder, Immune System --- Immune System Disorder
Choose an application
Despite a substantial improvement in controlling new infections of HIV over the last ten years, Mexico is experiencing a low-level epidemic with approximately 180,000 people living with HIV (Spectrum, 2013), making it the fourth ranking country in Latin America with regards to the number of people with the disease (PLHIV). The objective of increasing coverage and reducing inequality in the country is reflected in the objectives of the Specific Action Program (PAE) for the national response to HIV, AIDS and STI of 2013-2018 (Secretaria de salud), which seeks to decrease the effect of HIV and STIs, implement prevention strategies and provide comprehensive care for vulnerable population groups and those living in poverty. The possibility of achieving the objectives of the PAE is closely related to the total amount of resources that Mexico can commit to fighting HIV and the way these resources are allocated. In the hopes of assisting the Government of Mexico in further strengthening its HIV investment, the authors try to answer the question How can HIV funding be optimally allocated to the combination of HIV response interventions that will yield the highest impact in the shortest period. The study found that despite the overall greater costs of treatment with ART, this is the most cost-effective program. ART not only reduces deaths but is an effective measure to prevent new infections due to the reduction of viral load to undetectable levels. As such, the most cost-effective allocation - with no additional resources of current Program funds, is to scale up treatment, by about 4 to 8 percent, to maximize ART coverage while slightly reducing overall allocations to general population prevention.This slight increase would avert 4,235 deaths and 3,371 new infections, and improve health outcomes by around 6 percent. To increase the value-for-money of existing resources, allocation efficiency would also require the strengthening of CENSIDA's stewardship role, to ensure that the funds transferred are invested as they were initially earmarked.
Choose an application
Strengthening public health, that is, improving the health of whole populations through action across all relevant sectors is at the heart of the World Bank's mission. This policy note takes stock of the global progress in public health over the past decade; lays out the challenges that must be addressed for this progress to be sustained and accelerated; and proposes an approach for the Bank to maximize its contribution to public health in the years ahead. This note comes at a critical juncture, given the important gains made in public health over the past decade. Key global indicators, including life expectancy at birth, under-five mortality and maternal mortality, have shown steady improvement, while initiatives such as the scale-up of polio vaccination and the distribution of bed nets to combat malaria have saved millions of lives. The Bank is proud to have worked with countries and development partners to contribute to these achievements. The note emphasizes that the Bank will need to root its future public health efforts in its areas of comparative advantage, including its capacity to analyze the economic and development impact of health investments, and its extensive experience in working across sectors for health results. The Bank finances investments in all the sectors that impact health, including education, social protection, infrastructure, water and sanitation and transportation, to name a few, and is well placed to help mobilize such sectors through coordinated, population-based interventions to improve health and accelerate development. Given its analytic capability, the Bank has a potentially critical role to play in focusing finite budgets on the most cost-effective actions, particularly in prevention and health promotion.
Access to Health Services --- Burns --- Capacity Building --- Cervical Cancer --- Child Care --- Child Health --- Child Mortality --- Childbirth --- Climate Change --- Communicable Diseases --- Developing Countries --- Development Policy --- Diabetes --- Disabilities --- Disasters --- Disease Control & Prevention --- Drugs --- Early Childhood --- Fertility Rates --- Food Security --- Good Governance --- Health Economics & Finance --- Health Education --- Health Monitoring & Evaluation --- Health Outcomes --- Health Policy --- Health Systems Development & Reform --- Health, Nutrition and Population --- Household Income --- Human Capital --- Human Resources --- Hygiene --- Indoor Air Pollution --- Injuries --- International Cooperation --- Life Expectancy --- Malaria --- Marketing --- Maternal Mortality --- Measles --- Migration --- Millennium Development Goals --- Morbidity --- Mortality --- Mortality Rate --- Nutrition --- Official Development Assistance --- Oral Rehydration therapy --- Polio --- Public Health --- Public Health Promotion --- Quality Control --- Reproductive Health --- Sanitation --- Social Change --- Social Development --- Technical Assistance --- Tetanus --- Tuberculosis --- Urban Areas --- Urban Population --- Urbanization --- Vaccines --- Violence --- Whooping Cough --- Workers --- World Health Organization
Listing 1 - 3 of 3 |
Sort by
|